2 Charts That Every Biotech Investor Must See
Would you start a project if you knew that it only had a 13.8% chance of succeeding? For biotech companies, there isn't much of a choice in the matter, given that those are the odds of a medicine in development making it through all the phases of clinical trials to become commercialized.
The fact that developing new medicines is really risky isn't new to most biotech investors, though. But the fact that it's getting harder and more expensive to make new drugs might be. Let's take a look at two trends that demonstrate how the game is getting fiercer for biopharmas to understand how the industry is changing over time.
Image source: Getty Images.
Source Fool.com
